RxDoctor Payments Data

Jessica Heiring

Neurology · Golden Valley, MNNPI 1326095092

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $127,330 of the $149,405 with a category attached, or 85.2%. 9 manufacturers reported payments, led by Lilly USA, LLC at 46.7% of the total. Reporting peaked in 2019 at $81,692 and has fallen 100.0% since, to $20 in 2025. Among neurology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$149,405in general payments, 2019–2025

Across 264 payments — averaging $565.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$70K
  • AbbVie$40K
  • Teva Pharmaceuticals USA, Inc.$40K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$106
  • Sunovion Pharmaceuticals Inc.$33
  • Cvrx, Inc.$24
  • plus $49 from 3 others
$412,054in research payments, 2019–2025

Across 40 payments — averaging $10,301 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$412K

What the payments were for

  • Consulting fees$11,5258%
  • Speaking & faculty fees$127,33085%
  • Travel & lodging$7,1645%
  • Food & beverage$3,1842%
  • Education$2030%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$149,405 in reported general payments places this provider in the 95th percentile of 434 neurology providers in Minnesota.

See all neurology providers in Minnesota

Medicare billing

Part B allowed, 2024
$10,988
Medicare patients
67
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Golden Valley

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →